Hims & Hers Q2 Earnings: Portfolio Cure
Updated Aug. 23, 2023
Hims continues trending down. The stock remains appealing on these dips with software like margins and growth rates.
Update Aug. 17, 2023
Hims & Hers continues to dip following another great earnings report. The online health and wellness platform continues to shift towards profitable precisions treatments, but the market has missed the shift. Definitely a stock to watch for when Hims hits the lows.
Original article published on Aug. 16
- Hims & Hers Health, Inc. falls despite a strong Q2 '23 earnings report.
- The company remains on the path to a 2025 revenue target of $1.2+ billion.
- The stock is cheap at 1.3x forward EV/S targets for a high gross margin business.
- Out Fox The Street members get exclusive access to our real-world portfolios. See all of our investments here »